Journal of Biomedical Semantics - a new open access journal from BioMed Central

Editors-in-Chief
Joseph D Buxbaum, Director, Seaver Autism Center for Research and Treatment, Professor of Psychiatry, Neuroscience, and Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, United States of America
Simon Baron-Cohen, Director, Autism Research Centre, Professor of Developmental Psychopathology, University of Cambridge, United Kingdom

Molecular Autism is an online open access journal that gives special emphasis to basic, translational, and clinical research into the molecular basis of autism and related neurodevelopmental conditions.

Molecular Autism will publish research that relates causal and risk factors with these conditions, including research leading to model systems and novel therapeutics. This will include studies into genetics, molecular neurobiology, neuropathology, imaging and biomarkers, with a focus on potential applications for intervention.

Molecular Autism will also publish articles on screening, diagnosis and classification, looking at phenotypic presentation, particularly if such articles have a molecular component or have implications for a multi-level approach.

Although the primary focus is on conditions in the autism spectrum (including Asperger syndrome), the scope encompasses molecular research into related neurodevelopmental conditions such as specific language impairment, dyspraxia, and specific or general developmental delays; and into related medical syndromes such as fragile X syndrome, tuberous sclerosis, and Rett syndrome.

Molecular Autism considers the following article types:

  • Research: reports of data from original research. These articles will form the major content of the journal.
  • Reviews: comprehensive, authoritative, descriptions of any subject within the scope of the journal.
  • Commentaries: short, focused and opinionated articles on any subject within the journal's scope. These articles are usually related to a contemporary issue, such as recent research findings, and are often written by opinion leaders invited by the Editorial Board.
  • Short reports: brief reports of data from original research.
  • Viewpoints: short opinion pieces focusing on the latest high-impact research.


Molecular Autism is accepting submissions; please use the online submission system to submit your manuscript. For all enquiries about the journal, please contact: editorial@molecularautism.com.

Sign up for regular Molecular Autism updates

   

Editors-in-Chief
Simon Baron-Cohen, United Kingdom
Joseph D Buxbaum, United Kingdom


Editorial Board

David G Amaral (United States)
Sabine Bahn (United Kingdom)
Agatino Battaglia (Italy)
Mark Bear (United States)
Matthew Belmonte (United States)
Catalina Betancur (France)
Rita Cantor (United States)
Bhismadev Chakrabarti (United Kingdom)
John Constantino (United States)
Bernie Devlin (United States)
Frank Dudbridge (United Kingdom)
Evan Eichler (United States)
Jean-Pierre Fryns (Belgium)
Jozef Gecz (Australia)
Dan Geschwind (United States)
James F Gusella (United States)
Randi Hagerman (United States)
Markus Heinrichs (Switzerland)
Patrick Hof (United States)
Ami Klin (United States)

Rebecca Knickmeyer (United States)
Janine LaSalle (United States)
David H Ledbetter (United States)
Bennett Leventhal (United States)
F J Livesey (United Kingdom)
Catherine Lord (United States)
James McCracken (United States)
Judith Miles (United States)
Anthony Monaco (United Kingdom)
Richard Nowakowski (United States)
Antonio Persico (Italy)
Louis Reichardt (United States)
Susan Santangelo (United States)
Charles E Schwartz (United States)
David Skuse (United Kingdom)
Matthew State (United States)
Peter Szatmari (Canada)
Herman van Engeland (Netherlands)
Steven Warren (United States)
Larry J Young (United States)